ArticleJACC. Case reports2026
Feasibility and Safety of Atrioventricular Node Pacing in a Patient With Heart Failure and Atrioventricular Block: Results at 2-Year Follow-Up.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConduction system pacing (CSP) serves as a physiological alternative for managing heart failure and atrioventricular block. CASE SUMMARY: A 77-year-old woman was admitted with worsening shortness of breath. Her diagnoses included chronic heart failure classified as NYHA functional class IV, permanent atrial fibrillation, third-degree atrioventricular block after pacemaker implantation, and rheumatic heart valve disease. Atrioventricular node pacing (AVNP) was successfully achieved, with a stable threshold of 0.75 V at 0.4 ms. Over a 2-year period, the patient's left ventricular ejection fraction improved from 26% to 44%, left ventricular end-diastolic diameter decreased from 63 to 56 mm, and NYHA functional classification improved from IV to II. DISCUSSION: AVNP may present a viable alternative for patients experiencing failure of His bundle pacing and left bundle branch pacing. This case demonstrates to our knowledge the first report of AVNP with sustained electrophysiological stability and clinical efficacy during a 2-year follow-up, thereby addressing existing gaps in the applicability of CSP for patients with anatomically complex conditions. TAKE-HOME MESSAGE: AVNP may provide an alternative for patients with failure of traditional CSP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.